Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)

China flag China · Delayed Price · Currency is CNY
12.39
-0.24 (-1.90%)
Sep 6, 2024, 3:00 PM CST
6.81%
Market Cap 19.95B
Revenue (ttm) 3.77B
Net Income (ttm) -408.93M
Shares Out 1.61B
EPS (ttm) -0.26
PE Ratio n/a
Forward PE 22.53
Dividend 0.10 (0.81%)
Ex-Dividend Date Jul 8, 2024
Volume 6,220,083
Open 12.60
Previous Close 12.63
Day's Range 12.33 - 12.61
52-Week Range 10.45 - 16.40
Beta 0.37
Analysts n/a
Price Target n/a
Earnings Date Oct 29, 2024

About Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tige... [Read more]

Sector Healthcare
Founded 2000
Employees 1,451
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.